CAS: 252979-43-4 - N-[2-(2-Furyl)-8-propyl-8H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-yl]-N'-(4-methoxyphenyl)urea
Formula:C21H20N8O3
- Synonyms:
- Mre-3008
- Mre-3008-F20
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | MRE-3008F20 REF: TR-M750105CAS: 252979-43-4 | - - - | 5,339.00 € | Thu 20 Feb 25 |
 | MRE-3008F20 REF: 3D-BM177371CAS: 252979-43-4 | Min. 95% | 6,000.00 € | Fri 21 Feb 25 |
 | MRE3008F20 REF: TM-T16132CAS: 252979-43-4 | 97.66% | 69.00 €~2,088.00 € | Fri 28 Feb 25 |
MRE-3008F20
Controlled ProductCAS:252979-43-4
Formula:
C21H20N8O3
Color and Shape:
Neat
Molecular weight:
432.435
Ref: TR-M750105
| 1g | 5,339.00 € |
Estimated delivery in United States, on Thursday 20 Feb 2025
MRE-3008F20
CAS:252979-43-4
MRE-3008F20 is a diagnostic agent that is used to determine the presence of cardiac or …
Formula:
C21H20N8O3
Purity:
Min. 95%
Molecular weight:
432.44 g/mol
Ref: 3D-BM177371
| 750mg | 6,000.00 € |
Estimated delivery in United States, on Friday 21 Feb 2025
MRE3008F20
CAS:252979-43-4
MRE3008F20 is an AA3R antagonist that inhibits Cl-IB-MECA-induced cAMP production and can be used to …
Formula:
C21H20N8O3
Purity:
97.66%
Color and Shape:
Solid
Molecular weight:
432.44
Ref: TM-T16132
| 1mg | 69.00 € | ||
| 2mg | 91.00 € | ||
| 5mg | 149.00 € | ||
| 10mg | 212.00 € | ||
| 25mg | 360.00 € | ||
| 50mg | 536.00 € |
Estimated delivery in United States, on Friday 28 Feb 2025
